Product Information
TACROLIMUS 0.03% OINTMENT is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $0.6445 per GM under NDC 00168041799. Its NADAC has been published 528 times since Feb 18, 2015.
Strength
.3 mg/g
NDC
00168041799
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA200744On Market Since
9/9/2014
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.03% OINTMENT has been published 528 times since Feb 18, 2015, and over the history we have for it it has declined 88.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6445 per GM |
|---|---|
| All-time high | $6.1613 (Jun 15, 2016) |
| All-time low | $0.5757 (Apr 22, 2026) |
| 52-week high | $0.8298 |
| 52-week low | $0.5757 |
| Median price | $2.7675 |
| Average price | $3.0862 |
| Largest weekly change | +75.9% (Jan 18, 2023) |
| Weeks tracked | 528 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.03% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.03% OINTMENT, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $0.6445 per GM (NDC 00168041799), effective Jun 24, 2026.
How has the price of TACROLIMUS 0.03% OINTMENT changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.03% OINTMENT has declined 88.9%. It has been tracked across 528 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.03% OINTMENT?
Since Feb 18, 2015, the NADAC for TACROLIMUS 0.03% OINTMENT has ranged from a low of $0.5757 (Apr 22, 2026) to a high of $6.1613 (Jun 15, 2016), with a median of $2.7675 per GM.
Are there cheaper alternatives to TACROLIMUS 0.03% OINTMENT?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TACROLIMUS 0.03% OINTMENT, but none are currently priced below it.
Who manufactures TACROLIMUS 0.03% OINTMENT?
TACROLIMUS 0.03% OINTMENT (NDC 00168041799) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification